首页> 美国卫生研究院文献>Turkish Journal of Hematology >Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation
【2h】

Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation

机译:造血干细胞移植中铁超载及其相关并发症的最新研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Iron overload is an adverse prognostic factor for patients undergoing hematopoietic stem cell transplantation (HSCT). In the HSCT setting, pretransplant and early posttransplant ferritin and transferrin saturation were found to be highly elevated due to high transfusion requirements. In addition to that, post-HSCT iron overload was shown to be related to infections, hepatic sinusoidal obstruction syndrome, mucositis, liver dysfunction, and acute graft-versus-host disease. Hyperferritinemia causes decreased survival rates in both pre- and posttransplant settings. Serum ferritin levels, magnetic resonance imaging, and liver biopsy are diagnostic tools for iron overload. Organ dysfunction due to iron overload may cause high mortality rates and therefore sufficient iron chelation therapy is recommended in this setting. In this review the management of iron overload in adult HSCT is discussed.
机译:铁超负荷是接受造血干细胞移植(HSCT)的患者的不良预后因素。在HSCT设置中,由于高输血要求,发现移植前和移植后早期铁蛋白和转铁蛋白饱和度高度升高。除此之外,HSCT后铁超负荷还与感染,肝窦窦阻塞综合征,粘膜炎,肝功能障碍和急性移植物抗宿主病有关。高铁蛋白血症导致移植前和移植后生存率降低。血清铁蛋白水平,磁共振成像和肝活检是铁超负荷的诊断工具。铁超负荷引起的器官功能障碍可能导致较高的死亡率,因此,在这种情况下,建议使用足够的铁螯合疗法。在这篇综述中,讨论了成人HSCT中铁超负荷的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号